Results 261 to 270 of about 117,575 (311)
Some of the next articles are maybe not open access.

Growth of Ruthenium and Ruthenium oxide nanoplates

MRS Proceedings, 2011
ABSTRACTBy carefully manipulating and controlling the growth conditions, Ruthenium (Ru) and ruthenium oxide (RuO2) two-dimensional (2-D) nanostructure were self-assembled into a stack of plates on indium tin oxide coated glass substrate. The nanoplates were grown in a horizontal hot-wall metalorganic chemical vapor deposition (MOCVD) from ruthenocene ...
Lamartine Meda, Geoffrey D. Stevens
openaire   +1 more source

Ruthenium Anticancer Drugs

2004
Several ruthenium-based compounds have been proven to posses interesting biological properties that can lead to innovative drugs, particularly in the field of cancer treatment. The capacity of such compounds to bind to imine groups with a relatively high affinity has raised a great interest about the possibility to develop anticancer agents.
ALESSIO, ENZO   +3 more
openaire   +3 more sources

ChemInform Abstract: Sulfato Complexes of Ruthenium with a Ruthenium‐Ruthenium Bond.

ChemInform, 1989
AbstractThe ruthenium complexes (IV) are prepared as shown in the scheme.
A. N. ZHILYAEV   +4 more
openaire   +1 more source

Ruthenium and ruthenium-based contacts to GaAs

Applied Surface Science, 1993
This paper deals with the outstanding electrical and structural properties of Ru-based Schottky and ohmic contacts fabricated by electron beam evaporation on n- and p+ -type GaAs, respectively. The effective and flatband barrier heights were evaluated by standard current-voltage (I–V)(T) and capacitance-voltage (C–V)(T) measurements, over the ...
G. Myburg   +7 more
openaire   +1 more source

Ruthenium

Fresenius' Zeitschrift für analytische Chemie, 1960
Klaus Brodersen, E. Bankmann
openaire   +2 more sources

Ruthenium

Fresenius' Zeitschrift f�r Analytische Chemie, 1963
A. Dornemann, K. H. Neeb
openaire   +2 more sources

Ruthenium

Reactions Weekly, 2023
openaire   +1 more source

Ruthenium-106 Brachytherapy

2011
Brachytherapy is the most common method for treating uveal melanoma, and currently the ruthenium-106 (Ru-106) and iodine-125 (I-125) applicators are the most frequently used. Ru-106 applicators were introduced by Prof. Peter Lommatzsch in the 1960s, and since then have been used widely by many ocular oncologists, mainly in Europe. The Ru-106 isotope is
openaire   +2 more sources

Ruthenium-Catalyzed Cycloadditions to Form Five-, Six-, and Seven-Membered Rings

Chemical Reviews, 2021
Rosalie S Doerksen   +2 more
exaly  

Catalysis with Colloidal Ruthenium Nanoparticles

Chemical Reviews, 2020
M Rosa Axet, Karine Philippot
exaly  

Home - About - Disclaimer - Privacy